Related Experiment Video
Updated: Jan 28, 2026

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
Published on: September 6, 2024
[Multidrug-resistant gram-negative rods in the intensive care unit : Epidemiology, prevention and treatment options]
1Dienststelle Erlangen, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Eggenreuther Weg 43, 91058, Erlangen, Deutschland. giuseppe.valenza@lgl.bayern.de.
Abstract:
In Germany, multidrug-resistant gram-negative rods (MRGN) are classified in two groups, namely those with resistance against three (3MRGN) and those with resistance against four (4MRGN) of the following antibiotic groups: acylureidopenicillins, third or fourth generation cephalosporins, fluoroquinolones and carbapenemes. The rate of 3MRGN enterobacteria and 4MRGN Pseudomonas aeruginosa has significantly increased in German intensive care units from 2008-2014. In contrast, 4MRGN enterobacteria are still rare. The 3MRGN and 4MRGN phenotypes can be associated with different antimicrobial resistance mechanisms such as the production of extended-spectrum β‑lactamases (ESBL) or carbapenemases. The strategy for the prevention and control of MRGN in intensive care units includes basic hygiene measures as well as special measures such as contact isolation of patients. The treatment of MRGN infections should be carried out according to the antimicrobial susceptibility test results.
Insights
Multidrug-resistant gram-negative rods (MRGN) are increasing in German ICUs. Strategies include hygiene, isolation, and susceptibility-guided treatment for 3MRGN and 4MRGN infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Multidrug-resistant gram-negative rods (MRGN) are a growing concern in healthcare settings.
- In Germany, MRGN are classified as 3MRGN (resistance to 3 antibiotic groups) or 4MRGN (resistance to 4 antibiotic groups).
- Specific antibiotic groups include acylureidopenicillins, cephalosporins, fluoroquinolones, and carbapenemes.
Purpose of the Study:
- To analyze the trends of 3MRGN and 4MRGN pathogens in German intensive care units (ICUs).
- To understand the antimicrobial resistance mechanisms associated with MRGN phenotypes.
- To outline current strategies for MRGN prevention, control, and treatment in ICUs.
Main Methods:
- Retrospective analysis of MRGN data from German ICUs (2008-2014).
- Classification of MRGN based on resistance profiles against key antibiotic classes.
- Review of antimicrobial resistance mechanisms (e.g., ESBL, carbapenemases).
Main Results:
- Significant increase in 3MRGN Enterobacteria and 4MRGN Pseudomonas aeruginosa rates in German ICUs from 2008-2014.
- 4MRGN Enterobacteria remain rare.
- Phenotypes linked to resistance mechanisms like ESBL and carbapenemases.
Conclusions:
- Intensified surveillance and control measures are crucial for combating rising MRGN rates in ICUs.
- Adherence to basic hygiene and special isolation precautions is essential.
- Tailored antimicrobial therapy based on susceptibility testing is vital for effective MRGN infection management.
More Related Videos
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Treatment Resistant Cancers
Measurement: Derived Units
Measurement: Standard Units
Introduction to Epidemiology
Causality in Epidemiology

